Globus Medical Inc (NYSE: GMED) stock enjoyed a major increase of 20.2% on 5/8/24. The shares closed at $61.73. Moreover, trading volume in this advance was exceptionally high at 597% of normal. The stock has performed in line with the market over the last nine months and has risen 24.0% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, GMED is expected to continue to be a modest Value Builder.
Globus Medical has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Globus Medical has a good Appreciation Score of 76 but a neutral Power Rating of 41, with the High Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment